Invention Grant
- Patent Title: GLP-1R modulating compounds
-
Application No.: US17690851Application Date: 2022-03-09
-
Publication No.: US12180197B2Publication Date: 2024-12-31
- Inventor: Gediminas J. Brizgys , Chienhung Chou , Jeromy J. Cottell , Chao-I Hung , Michael L. Mitchell , Scott D. Schroeder , Nathan D. Shapiro , Suzanne M. Szewczyk , James G. Taylor , Nathan E. Wright , Sheila M. Zipfel
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: C07D405/14
- IPC: C07D405/14 ; A61K31/4545 ; A61K31/4725 ; A61K45/06 ; C07D401/14 ; C07D413/14 ; C07D417/14
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.
Public/Granted literature
- US20220306614A1 GLP-1R MODULATING COMPOUNDS Public/Granted day:2022-09-29
Information query
